Inhaled insulin: Phase I update

Alkermes Inc. (ALKS), Cambridge, Mass. Product: Inhaled insulin Business: Metabolic Therapeutic category: Metabolism Target: Insulin receptors Description: Insulin formulated with ALKS's AIR pulmonary...